Amanote Research
Register
Sign In
Evolving Therapeutic Role of Bisphosphonates in Multiple Myeloma
British Journal of Cancer
- United Kingdom
doi 10.1038/sj.bjc.6602694
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
July 1, 2005
Authors
A U Ural
F Avcu
Publisher
Springer Science and Business Media LLC
Related search
The Role of Bisphosphonates in Multiple Myeloma: Mechanisms, Side Effects, and the Future
Oncologist
Cancer Research
Medicine
Oncology
Effect of Spacing Intravenous Bisphosphonates in Patients With Multiple Myeloma in Plateau Phase
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
HDAC3 Regulates DNMT1 Expression in Multiple Myeloma: Therapeutic Implications
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
TRAF6 Activation in Multiple Myeloma: A Potential Therapeutic Target
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
The Therapeutic Potential of Cell Cycle Targeting in Multiple Myeloma
Oncotarget
Oncology
Evolving Therapy in Relapsed Myeloma
Cancer therapy & Oncology International Journal
FOXM1 Is a Therapeutic Target in High-Risk Multiple Myeloma
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Investigating the Efficacy of Bisphosphonates Treatment Against Multiple Myeloma Induced Bone Disease Using a Computational Model
Bio-Medical Materials and Engineering
Medicine
Biomaterials
Biomedical Engineering
Role of Allogeneic Stem Cell Transplantation in Multiple Myeloma
Seminars in Hematology
Hematology
